Community/Retail

Rebecca Sleeper, PharmD, FCCP, FASCP, BCPS, of the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, discusses how a lack of sex and gender specific patient care education can impact a pharmacist’s work with their patients.

Tixagevimab co-packaged with cilgavimab is one of the only 2 antibody therapies issued emergency use authorization by the FDA that showed neutralizing activity against omicron and all other variants of concern.

A survey was administered electronically to key kidney care stakeholders in 182 International Society of Nephrology (ISN)-affiliated countries, with 88% responding and 97% answering the survey items related to kidney nutrition care.

The results of an analysis from investigators from Baylor College of Medicine suggest that supplementation with GlyNAC might be beneficial to those who have the virus.

Alyson McGregor, MD, of Brown University discusses the focus of her research into sex and gender in emergency medicine.

Arnicare temporarily relieves muscle pain and relieves stiffness due to minor injuries.

The efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors.

In patients with gastroparesis, the stomach's motility is slowed down or doesn't work at all, preventing proper emptying.

The approval marks the first small interfering RNA therapy for low-density lipoprotein cholesterol reduction.

Eli Lilly says the drug in combination with TCS also achieved all key secondary endpoints versus the placebo for individuals with AD.

1960-2021

The study analyzed blood samples taken from individuals infected with COVID-19, those who had been vaccinated with a 2-dose schedule and a third booster dose, and those who had reported previous infection from other COVID-19 variants of concern.

This is an update to the 2011 AAN guideline on the treatment of painful diabetic neuropathy, according to a press release.

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.

The existing EUA was also amended to reduce the time for booster dose administration from a minimum of 6 months to at least 5 months following completion of the primary COVID-19 vaccine series.

Pharmacists can play a key role in providing education and guidance to patients with glaucoma.

Witch hazel is used for conditions such as diarrhea, mucus colitis, and various other skin irritations.

The FDA has granted emergency use authorization for a COVID-19 at-home test (Roche) and a rapid COVID-19 antigen self-test (Clinitest; Siemens Healthineers).

Individuals receiving the therapy had an 87% reduction in risk for the composite primary endpoint of virus-related hospitalization or all-cause death by day 28.

The therapeutic is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022.

When assessing treatments for flu and cold symptoms, it is important for the pharmacist to consider not only the patient’s current medication regimen, but also other OTCs and disease states.

The research team compared the monthly average blood pressures between 2018 and 2019 with blood pressure measures from January through March 2019 to January through March 2020.

The findings showed that people with HIV were 68% more likely to develop heart failure than people who did not have HIV.

Immune B cells secrete immunoglobin A antibodies that work on mucosal surfaces in the nose, stomach, and lungs.

Curoxen helps to prevent infection and treats cuts, scrapes, blisters, and burns.

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.

Symptoms of Gaucher disease include abdominal complaints, skeletal abnormalities, and blood disorders.

Avapro (Irbesartan) is indicated for the treatment of hypertension and used to lower blood pressure.

OTC case studies for December 2021.

The FDA approves anifrolumab-fnia injection (Saphnelo; AstraZeneca) for the treatment of adults with moderate to severe system- ic lupus erythematosus (SLE) who are receiving standard therapy.